-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TN3OF+UgrzCw6m3nnhUsNgqzcky3ts8dIY20aIs0nyw1Uf5MIHR++m8g6d62PKen 8ev6G+XmNqIpFqHpz7jmsQ== 0000889812-97-000385.txt : 19970222 0000889812-97-000385.hdr.sgml : 19970222 ACCESSION NUMBER: 0000889812-97-000385 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970212 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GIBRALTAR PACKAGING GROUP INC CENTRAL INDEX KEY: 0000882830 STANDARD INDUSTRIAL CLASSIFICATION: PAPERBOARD CONTAINERS & BOXES [2650] IRS NUMBER: 470496290 STATE OF INCORPORATION: DE FISCAL YEAR END: 0629 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-43376 FILM NUMBER: 97525510 BUSINESS ADDRESS: STREET 1: 274 RIVERSIDE AVE CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 2032270400 MAIL ADDRESS: STREET 1: 274 RIVERSIDE AVE CITY: WESTPORT STATE: CT ZIP: 06880 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CHASE VENTURE CAPITAL ASSOCIATES L P CENTRAL INDEX KEY: 0001015240 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 380 MADISON AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2126223100 MAIL ADDRESS: STREET 1: 380 MADISON AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SC 13D 1 SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* GIBRALTAR PACKAGING GROUP, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 374758-100 ----------------------- (CUSIP Number) Harvey M. Eisenberg, Esq. O'Sullivan, Graev & Karabell, LLP 30 Rockefeller Plaza 41st Floor New York, New York 10112 (212) 408-2400 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 1, 1997 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject to this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) and (4), check the following box / /. Check the following box if a fee is being paid with the statement / /. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filed out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 9 Pages - ------------------------------- --------------------------- CUSIP No. 374758-100 SCHEDULE 13D Page 2 of 9 Pages - ------------------------------- --------------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Chase Venture Capital Associates, L.P. (f/k/a Chemical Venture Capital Associates, A California Limited Partnership) 13-337-6808 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* SC - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION California - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 274,739 ------------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY -0- OWNED BY ------------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITh 274,739 ------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 274,739 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.5% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 9 Pages SCHEDULE 13D Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100 - -------------------------------------------------------------------------------- Preliminary Note All information set forth herein has been adjusted to reflect a change in the name and address of the reporting person. Item 2. Identity and Background. This statement is being filed by Chase Venture Capital Associates, L.P. (f/k/a Chemical Venture Capital Associates, A California Limited Partnership) (hereinafter referred to as "CVCA"), whose principal business office is located at 380 Madison Avenue, 12th Floor, New York, New York 10017. The general partner of CVCA is Chase Capital Partners (f/k/a Chemical Venture Partners), a New York general partnership ("CCP"), whose principal business office is located at the same address as CVCA. Set forth below are the names of each general partner of CCP who is a natural person. Each such general partner is a U.S. citizen, whose principal occupation is general partner of CCP and whose principal business office address (except for Messrs. Ferguson and Soghikian) is c/o Chase Capital Partners, 380 Madison Avenue, 12th Floor, New York, New York 10017. John R. Baron Mitchell J. Blutt, M.D. Arnold L. Chavkin David L. Ferguson Michael R. Hannon Donald J. Hofmann Stephen P. Murray Brian J. Richmand Shahan D. Soghikian Jeffrey C. Walker Damion E. Wicker, M.D. Mr. Ferguson's principal business office address is c/o Chase Capital Partners, 840 Apollo Street, Suite 223, El Segundo, California 90245. Mr. Soghikian's principal business office address is c/o Chase Capital Partners, 125 London Wall, London EC2Y5AJ, England. Jeffrey C. Walker is the managing general partner of CCP. The remaining general partners of CCP are Chemical Capital Corporation, a New York corporation ("Chemical Capital"), CCP Principals, L.P. (f/k/a CVP Principals, L.P.), a Delaware limited partnership ("Principals") and CCP European Principals, L.P., a Delaware limited partnership ("European Principals"), each of whose principal business office is located at the same address as CVCA. Chemical Capital is a wholly owned subsidiary of The Chase Manhattan Corporation (f/k/a Chemical Banking Corporation), a Delaware corporation, whose principal business office is located at the same address as CVCA. The general partner of each of Principals and European Principals is Chemical Capital. Set forth in Schedule A hereto and incorporated herein by reference are the names, business addresses, principal occupations of each executive officer of Chemical Capital, each of whom is a U.S. citizen. Page 3 of 9 Pages SCHEDULE 13D Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100 - -------------------------------------------------------------------------------- The Chase Manhattan Corporation ("Chase") is a Delaware corporation engaged (primarily through subsidiaries) in the commercial banking business with its principal office located at 270 Park Avenue, New York, New York 10017. Set forth in Schedule B hereto and incorporated herein by reference are the names, business addresses, principal occupations and employments of each executive officer and director of Chase, each of whom is a U.S. citizen. To CVCA's knowledge, the response to Items 2(d) and (e) of Schedule 13D is negative with respect to CVCA and all persons regarding whom information is required hereunder by virtue of CVCA's response to Item 2. Insofar as the requirements of Items 3-6 inclusive of this Schedule 13D Statement require that, in addition to CVCA, the information called for therein should be given with respect to each of the persons listed in this Item 2, including CCP, CCP's individual general partners, Chemical Capital, Chemical Capital's executive officers and directors, Principals, and Principals' controlling partner, European Principals and European Principals' controlling partner, Chase and Chase's executive officers and directors, the information provided in Items 3-6 with respect to CVCA should also be considered fully responsive with respect to the aforementioned persons who have no separate interests in the Issuer's Common Stock which is required to be reported thereunder. Although the definition of "beneficial ownership" in Rule 13d-3 under the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), might also be deemed to constitute these persons beneficial owners of the Issuer's Common Stock acquired by CVCA, neither the filing of this statement nor any of its contents shall be deemed an admission that any of such persons is a beneficial owner of the Issuer's Common Stock acquired by CVCA or a member of a group together with CVCA either for the purpose of Schedule 13D of the Exchange Act or for any other purpose with respect to the Issuer's Common Stock. Item 7. Material to be Filed as Exhibits. *1. Agreement and Plan of Reorganization, dated as of April 28, 1993, among the Issuer, Acquisition, Holdings, Niemand, CVCA and the Other Shareholders (without Exhibits or Appendices). *2. Letter Agreement, dated April 28, 1993, between the Issuer and CVCA. ___________ * Filed previously *3. Registration Rights Agreement, dated as of April 28, 1993, among the Issuer, CVCA and the Other Shareholders. *4. Agreement Among Shareholders, dated as of April 28, 1993, among CVCA and the Other Shareholders. SCHEDULE A Item 2 information for executive officers and directors of Chemical Capital. SCHEDULE B Item 2 information for executive officers and directors of Chase. Page 4 of 9 Pages ______________ * Filed previously SCHEDULE 13D Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100 - -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 12, 1997 CHASE VENTURE CAPITAL ASSOCIATES, L.P. By: CHASE CAPITAL PARTNERS, its General Partner By: /s/ Jeffrey C. Walker ------------------------------------ Name: Jeffrey C. Walker Title: Managing General Partner Page 5 of 9 Pages SCHEDULE 13D Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100 - -------------------------------------------------------------------------------- SCHEDULE A CHEMICAL CAPITAL CORPORATION Executive Officers ------------------ President Jeffrey C. Walker** Executive Vice President Mitchell J. Blutt, M.D.** Vice President & Secretary Gregory Meridith* Vice President & Treasurer Donna L. Carter** Assistant Secretary Robert C. Carroll* Directors William B. Harrison, Jr.* Jeffrey C. Walker** - ---------- * Principal occupation is employee and/or officer of Chase. Business address is c/o The Chase Manhattan Corporation, 270 Park Avenue, New York, New York 10017. ** Principal occupation is employee of Chase and/or general partner of CCP. Business address is c/o Chase Capital Partners, 380 Madison Avenue, 12th Floor, New York, NY 10017. Page 6 of 9 Pages SCHEDULE 13D Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100 - -------------------------------------------------------------------------------- SCHEDULE B THE CHASE MANHATTAN CORPORATION Executive Officers* ------------------ Walter V. Shipley, Chairman and CEO Edward D. Miller, Senior Vice Chairman Thomas G. Labrecque, President and COO William B. Harrison, Jr., Vice Chairman Directors** --------- Principal Occupation or Employment; Name Business or Residence Address - ---- ----------------------------- Frank A. Bennack, Jr. President and Chief Executive Officer The Hearst Corporation 959 Eighth Avenue New York, NY 10019 Susan V. Berresford President The Ford Foundation 320 East 43rd Street New York, NY 10017 M. Anthony Burns Chairman, President and CEO Ryder System, Inc. 3600 N.W. S2nd Avenue Miami, FL 33166 H. Laurance Fuller Chairman of the Board and Chief Executive Officer Amoco Corporation 200 East Randolph Drive Chicago, IL 60601 - ---------- * Principal occupation is executive officer and/or employee of The Chase Manhattan Bank. Business address is c/o The Chase Manhattan Bank, 270 Park Avenue, New York, New York 10017. Each executive officer of Chase is a U.S. citizen. ** Each of the persons named below is a citizen of the United States of America. Page 7 of 9 Pages SCHEDULE 13D Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100 - -------------------------------------------------------------------------------- Principal Occupation or Employment; Name Business or Residence Address - ---- ----------------------------- Melvin R. Goodes Chairman of the Board and Chief Executive Officer Warner-Lambert Company 201 Tabor Road Morris Plains, NJ 07950 William H. Gray, III President and Chief Executive Officer United Negro College Fund, Inc. 8260 Willow Oaks Corporate Drive P.O. Box 10444 Fairfax, VA 22031 George V. Grune Retired Chairman and Chief Executive Officer the Reader's Digest Association, Inc. Chairman of the Board The DeWitt Wallace-Reader's Digest Fund Lila Wallace-Reader's Digest Fund 2 Park Avenue, 23rd Floor New York, NY 10016 William B. Harrison, Jr. Vice Chairman of the Board The Chase Manhattan Corporation 270 Park Avenue, 8th Floor New York, NY 10017-2070 Harold S. Hook Chairman of the Board American General Corporation 2929 Allen Parkway Houston, TX 77019 Helene L. Kaplan Of Counsel Skadden, Arps, Slate, Meagher & Flom 919 Third Avenue - Room 29-72 New York, NY 10022 Thomas G. Labracque President and Chief Operating Officer The Chase Manhattan Corporation 270 Park Avenue, 8th Floor New York, NY 10017-2070 J. Bruce Llewellyn Chairman of the Board The Philadelphia Coca-Cola Bottling Company, The Coca-Cola Bottling Company of Wilmington, Inc. and Queen City Broadcasting, Inc. The Philadelphia Coca-Cola Bottling Company 30 Rockefeller Plaza, 29th Floor New York, New York 10112 Page 8 of 9 Pages SCHEDULE 13D Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100 - -------------------------------------------------------------------------------- Principal Occupation or Employment; Name Business or Residence Address - ---- ----------------------------- Edward D. Miller Senior Vice Chairman of the Board The Chase Manhattan Corporation 270 Park Avenue, 8th Floor New York, NY 10017-2070 Edmund T. Pratt, Jr. Chairman Emeritus Pfizer Inc. Astors Lane Port Washington, NY 11050 Henry B. Schacht Chairman of the Board and Chief Executive Officer Lucent Technologies, Inc. 600 Mountain Avenue - Room 6A511 Murray Hill, NJ 07974 Walter V. Shipley Chairman of the Board and Chief Executive Officer The Chase Manhattan Corporation 270 Park Avenue, 8th Floor New York, NY 10017-2070 Andrew C. Sigler Retired Chairman of the Board and Chief Executive Officer Champion International Corporation 1 Champion Plaza Stamford, CT 06921 John R. Stafford Chairman, President and Chief Executive Officer American Home Products Corporation Five Giralda Farms Madison, NJ 07940 Marina v.N. Whitman Professor of Business Administration and Public Policy The University of Michigan School of Public Policy 411 Lorch Hall, 611 Tappan Street Ann Arbor, MI 48109-1220 Page 9 of 9 Pages -----END PRIVACY-ENHANCED MESSAGE-----